The Oncopro Prostate Cancer Screen Test is a specialized diagnostic tool designed to detect the presence of prostate cancer at an early stage. This advanced screening test is available at DNA Labs UAE, a leading facility in genetic and molecular diagnostics. The test works by analyzing specific markers that are often associated with prostate cancer, providing a non-invasive yet highly accurate assessment of an individual's risk for developing this type of cancer.
Priced at 5620 AED, the Oncopro Prostate Cancer Screen Test is a valuable investment for men, especially those who are at an increased risk due to factors such as age, family history, or genetic predispositions. By opting for this screening, individuals can gain crucial insights into their health, enabling early detection and the possibility of more effective treatment options if needed.
DNA Labs UAE is renowned for its state-of-the-art facilities and commitment to providing accurate, reliable, and timely diagnostic services. Choosing to undergo the Oncopro Prostate Cancer Screen Test at DNA Labs UAE means entrusting your health to experienced professionals who use cutting-edge technology to deliver comprehensive and personalized health insights.
The "Nx Gen Sequencing Maturity Onset Diabetes of Young (MODY) Test" offered by DNA Labs UAE represents a cutting-edge diagnostic approach for identifying the genetic mutations associated with MODY, a form of diabetes that typically manifests before the age of 25. MODY is characterized by its monogenic nature, meaning it results from mutations in a single gene, distinguishing it from the more common types of diabetes which are polygenic. This advanced test leverages Next Generation Sequencing (NGS) technology, allowing for the comprehensive analysis of multiple genes simultaneously with high accuracy and speed.
The MODY test is particularly crucial for individuals with a family history of diabetes or those exhibiting symptoms of diabetes at an unusually young age. Early and accurate diagnosis through this test can lead to personalized treatment plans, significantly improving the management of the condition and enhancing the quality of life for those affected.
At a cost of 5620 AED, the test is an investment in precision medicine, enabling healthcare providers to tailor interventions based on the specific genetic mutation present. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, clients are assured of receiving reliable and comprehensive diagnostic insights that can guide the management of MODY.
The "Acute Leukemia Diagnostic Comprehensive Profile Test," offered at DNA Labs UAE, is a specialized diagnostic tool designed to accurately identify and classify acute leukemia in patients. Priced at 5850 AED, this comprehensive test is crucial for the early detection and management of acute leukemia, a rapidly progressing cancer that affects the blood and bone marrow.
This test encompasses a range of diagnostic procedures aimed at identifying the specific type of leukemia, including its genetic markers, and the stage of the disease. By analyzing various blood components and bone marrow samples, the test provides healthcare professionals with essential information that guides treatment planning and prognosis estimation.
DNA Labs UAE utilizes advanced technology and methodologies to ensure high accuracy and reliability of the test results. The insights gained from the Acute Leukemia Diagnostic Comprehensive Profile Test enable personalized treatment approaches, potentially improving patient outcomes and survival rates.
The Chromofic Karyoarray Test, available at DNA Labs UAE for a cost of 5850 AED, is a cutting-edge diagnostic tool designed to analyze chromosomal abnormalities with high precision. This test employs the latest microarray technology to examine the entire genome, enabling the detection of various genetic disorders and conditions. Unlike traditional karyotyping, which provides a broader view of chromosomes, the Chromofic Karyoarray Test can identify much smaller changes in the DNA, such as deletions, duplications, and other structural variations that could be responsible for genetic diseases. This makes it an invaluable tool for genetic counseling, prenatal screening, and diagnosing unexplained developmental delays or intellectual disabilities in individuals. The test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accurate and reliable results.
The Chromultra Chromosome SNP HD Microarray Test is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to detect chromosomal abnormalities and single nucleotide polymorphisms (SNPs) with high precision. This test is particularly useful for identifying genetic disorders, understanding inherited conditions, and providing crucial information for personalized medicine approaches. By analyzing DNA samples, the Chromultra test can pinpoint variations and mutations that may be responsible for genetic diseases, offering insights that are vital for early detection, management, and treatment planning. The test is priced at 5850 AED, reflecting its comprehensive nature and the advanced technology it employs to deliver detailed genetic insights.
The Comprehensive Hereditary Cancer Panel 104 Genes Test, available at DNA Labs UAE for a cost of 5850 AED, is a cutting-edge genetic screening tool designed to assess an individual's risk for various types of hereditary cancers. This test examines 104 specific genes that have been scientifically linked to an increased risk of developing cancer, including but not limited to breast, ovarian, colorectal, and prostate cancers. By analyzing an individual's DNA, the test identifies genetic mutations that could predispose them to cancer, enabling early detection strategies or preventive measures to be implemented. This comprehensive approach to genetic testing is crucial for individuals with a family history of cancer, offering them invaluable insights into their genetic health and empowering them with information to make informed decisions regarding their healthcare and lifestyle choices. DNA Labs UAE provides this service with the utmost confidentiality and support, ensuring that individuals receive comprehensive counseling and guidance throughout the testing process.
The Spinocerebellar Ataxia (SCA) Extended Profile Test is a comprehensive genetic screening aimed at identifying mutations associated with various forms of Spinocerebellar Ataxia, a progressive, neurodegenerative disorder characterized by coordination and balance difficulties. This condition encompasses a group of genetic disorders that affect the cerebellum, the part of the brain that controls muscle coordination.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test covers a wide array of SCA subtypes, providing a thorough assessment for individuals experiencing symptoms or those with a family history of the condition. The test is particularly crucial for early detection, family planning, and to guide clinical management of the disorder.
The cost of the SCA Extended Profile Test is set at 4000 AED. This investment includes a detailed analysis of the patient's DNA to identify specific genetic mutations linked to the different types of Spinocerebellar Ataxia. The results from this test can offer valuable insights into the specific subtype of SCA, if present, and thereby inform more targeted and effective treatment strategies.
DNA Labs UAE employs cutting-edge technology and adheres to stringent quality standards to ensure the accuracy and reliability of test results. Given the complexity of SCA and the importance of genetic factors in its diagnosis and management, the SCA Extended Profile Test represents a critical step forward for individuals seeking answers and options for managing this challenging condition.
The Extended AML (Acute Myeloid Leukemia) Panel is a comprehensive diagnostic test designed to detect specific genetic mutations and translocations associated with AML. This panel targets several key genes, including BCR-ABL, AML1-ETO (also known as RUNX1-RUNX1T1), CBFB, PML-RARA, FLT3, NPM1, and CEBPA. These genetic markers are crucial for diagnosing AML, determining prognosis, and guiding treatment decisions. The presence or absence of these mutations can significantly influence a patient's response to certain therapies, making this panel an essential tool in personalized medicine for AML patients.
Performed at DNA Labs UAE, a leading facility in genetic testing, the Extended AML Panel is executed with precision and accuracy, ensuring reliable results for patients and healthcare providers. The cost of the test is 5400 AED, reflecting the comprehensive nature of the analysis and the advanced technology employed in the process. By identifying specific genetic abnormalities, this test can help in tailoring treatment plans to the individual's genetic profile, potentially improving outcomes in AML treatment.
Microarray 750K and Single Karyotyping AFCVSCBPOCPB Test is a comprehensive genetic test offered by DNA Labs UAE, designed to detect a wide range of genetic abnormalities and variations. This test utilizes advanced microarray technology capable of analyzing over 750,000 genetic markers, alongside single karyotyping techniques, to provide a detailed overview of an individual's genetic makeup. It is particularly useful in identifying genetic disorders, chromosomal abnormalities, and inherited diseases, thereby assisting in precise diagnosis and personalized treatment planning.
The test is priced at 5400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of results. It is recommended for individuals seeking in-depth genetic analysis for health reasons, as well as for couples planning to conceive, to assess any potential genetic risks that could be passed on to their offspring. With its comprehensive approach, the Microarray 750K and Single Karyotyping AFCVSCBPOCPB Test stands as a pivotal tool in modern genetic diagnostics and personalized medicine.
The NTRK1, NTRK2, and NTRK3 test is a specialized diagnostic examination performed to detect alterations in the NTRK genes, which are critical for the development and function of the nervous system. These genes can also play a significant role in the formation and growth of certain types of cancer when they become fused with other genes, leading to the continuous activation of signaling pathways that promote tumor growth and survival. The test is particularly relevant for patients with cancers that are suspected to have NTRK gene fusions, as it can provide essential information for personalized treatment options, including the use of TRK inhibitors that specifically target these gene alterations.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to identify the presence of any fusions involving the NTRK1, NTRK2, and NTRK3 genes. This process employs advanced molecular techniques to ensure high sensitivity and specificity in detecting these genetic abnormalities.
The cost of the NTRK1, NTRK2, and NTRK3 test at DNA Labs UAE is set at 5400 AED. While the price may seem significant, it reflects the complexity of the test and the profound impact its results can have on the management of cancer patients. By identifying NTRK gene fusions, oncologists can tailor treatment plans to exploit these genetic vulnerabilities, potentially improving patient outcomes with targeted therapies.
